RESUMEN
BACKGROUND: Pituitary pars intermedia dysfunction (PPID) develops slowly in aged horses as degeneration of hypothalamic dopaminergic neurons leads to proliferation of pars intermedia (PI) melanotropes through hyperplasia and adenoma formation. Dopamine (DA) concentrations and tyrosine hydroxylase (TH) immunoreactivity are markedly reduced in PI tissue of PPID-affected equids and treatment with the DA receptor agonist pergolide results in notable clinical improvement. Thus, we hypothesized that pergolide treatment of PPID-affected horses would result in greater DA and TH levels in PI tissue collected from PPID-affected horses versus untreated PPID-affected horses. To test this hypothesis, pituitary glands were removed from 18 horses: four untreated PPID-affected horses, four aged and four young horses without signs of PPID, and six PPID-affected horses that had been treated with pergolide at 2 µg/kg orally once daily for 6 months. DA concentrations and TH expression levels in PI tissues were determined by high performance liquid chromatography with electrochemical detection and Western blot analyses, respectively. RESULTS: DA and TH levels were lowest in PI collected from untreated PPID-affected horses while levels in the pergolide treated horses were similar to those of aged horses without signs of PPID. CONCLUSIONS: These findings provide evidence of restoration of DA and TH levels following treatment with pergolide. Equine PPID is a potential animal model of dopaminergic neurodegeneration, which could provide insight into human neurodegenerative diseases.
Asunto(s)
Agonistas de Dopamina/uso terapéutico , Dopamina/metabolismo , Enfermedades de los Caballos/tratamiento farmacológico , Pergolida/uso terapéutico , Enfermedades de la Hipófisis/veterinaria , Tirosina 3-Monooxigenasa/metabolismo , Envejecimiento , Animales , Caballos , Enfermedades de la Hipófisis/tratamiento farmacológico , Adenohipófisis Porción Intermedia/efectos de los fármacos , Adenohipófisis Porción Intermedia/patologíaRESUMEN
Clinicopathologic evaluation of renal function and renal disease in sick adult horses remains grounded in detection of azotemia, assessment of serum and urine electrolyte concentrations, and evaluation of urinalysis findings, including specific gravity, reagent strip analysis, and sediment examination. Because increases in serum or plasma urea nitrogen and creatinine concentrations are insensitive indicators of a decreased glomerular filtration rate, there is considerable interest in identifying novel biomarkers of renal function or injury in blood and urine, with serum symmetric dimethylarginine concentration being the most recent addition to the commercial market.
Asunto(s)
Enfermedades de los Caballos/patología , Enfermedades de los Caballos/orina , Enfermedades Renales/veterinaria , Animales , Biomarcadores/sangre , Biomarcadores/orina , Enfermedades de los Caballos/sangre , Caballos , Enfermedades Renales/patología , Enfermedades Renales/orina , Masculino , Urinálisis/veterinariaRESUMEN
The objective of this study was to determine whether there was an association between type of colloid administered and survival of horses with enterocolitis (N = 92). A retrospective review of medical records of horses with enterocolitis treated with plasma or hetastarch (HES) between January 1, 2005 and December 31, 2011 was performed. Data collected included signalment, outcome, physical and clinicopathologic findings, and volume and type of colloid administered. Sixty-nine horses (75%) were treated with plasma and 23 horses (25%) were treated with HES. After accounting for confounding variables, horses treated with plasma (80% survival) were more likely to survive to discharge than horses treated with HES (47% survival; P = 0.041) despite similar disease severity at admission. This study provides support that use of natural colloids may be superior to treatment with synthetic colloids in horses with enterocolitis. A prospective, multi-center trial comparing outcome of critically ill equine patients treated with natural or synthetic colloids is warranted.
Issue des chevaux avec entérocolite recevant un traitement de support par fluide oncotique avec soit du plasma ou de l'héta-amidon. L'objectif de la présente étude était de déterminer s'il y avait une association entre le type de colloïde administré et la survie de chevaux avec entérocolite (N = 92). Une revue rétrospective des dossiers médicaux de chevaux avec entérocolite traités avec du plasma ou de l'héta-amidon (HES) entre le 1er janvier 2005 et le 31 décembre 2011 fut effectuée. Les données amassées incluaient l'anamnèse, l'issue, les trouvailles physiques et clinico-pathologiques, ainsi que le volume et le type de colloïde administré. Soixante-neuf chevaux (75 %) furent traités avec du plasma et 23 chevaux (25 %) furent traités avec du HES. Après avoir pris en considération les variables confondantes, les chevaux traités avec le plasma (80 % de survie) étaient plus susceptibles de survivre jusqu'au congé que les chevaux traités avec HES (47 % de taux de survie; P = 0,041) malgré la similarité de la sévérité de la condition lors de l'admission. Cette étude fournie des arguments que l'utilisation de colloïdes naturels serait supérieure au traitement avec des colloïdes synthétiques chez des chevaux avec entérocolite. Une étude prospective, multicentres comparant l'issue de patients équins sévèrement malades traités avec des colloïdes naturels ou synthétiques est requise.(Traduit par Dr Serge Messier).
Asunto(s)
Enterocolitis/veterinaria , Derivados de Hidroxietil Almidón , Animales , Coloides , Enfermedades de los Caballos , Caballos , Plasma , Estudios Prospectivos , Estudios RetrospectivosRESUMEN
Equine thyroid disorders pose a diagnostic challenge in clinical practice because of the effects of nonthyroidal factors on the hypothalamic-pituitary-thyroid axis, and the horse's ability to tolerate wide fluctuations in thyroid hormone concentrations and survive without a thyroid gland. While benign thyroid tumours are common in older horses, other disorders like primary hypothyroidism or hyperthyroidism in adult horses and congenital hypothyroidism in foals are rare. There is a common misunderstanding regarding hypothyroidism in adult horses, especially when associated with the clinical profile of obesity, lethargy, and poor performance observed in dogs and humans. Low blood thyroid hormone concentrations are often detected in horses as a secondary response to metabolic and disease states, including with the nonthyroidal illness syndrome; however, it is important to note that low thyroid hormone concentrations in these cases do not necessarily indicate hypothyroidism. Assessing equine thyroid function involves measuring thyroid hormone concentrations, including total and free fractions of thyroxine (T4) and triiodothyronine (T3); however, interpreting these results can be challenging due to the pulsatile secretion of thyroid hormones and the many factors that can affect their concentrations. Dynamic testing, such as the thyrotropin-releasing hormone stimulation test, can help assess the thyroid gland response to stimulation. Although true hypothyroidism is extremely rare, thyroid hormone supplementation is commonly used in equine practice to help manage obesity and poor performance. This review focuses on thyroid gland pathophysiology in adult horses and foals, interpretation of blood thyroid hormone concentrations, and evaluation of horses with thyroid disorders. It also discusses the use of T4 supplementation in equine practice.
Asunto(s)
Enfermedades de los Perros , Enfermedades de los Caballos , Hipotiroidismo , Enfermedades de la Tiroides , Humanos , Caballos , Animales , Perros , Tirotropina/fisiología , Hormonas Tiroideas/fisiología , Enfermedades de la Tiroides/diagnóstico , Enfermedades de la Tiroides/tratamiento farmacológico , Enfermedades de la Tiroides/veterinaria , Tiroxina/uso terapéutico , Triyodotironina/fisiología , Hipotiroidismo/diagnóstico , Hipotiroidismo/veterinaria , Obesidad/veterinaria , Enfermedades de los Caballos/diagnóstico , Enfermedades de los Caballos/tratamiento farmacológico , Suplementos DietéticosRESUMEN
The aim of this consensus statement is to summarize and appraise scientific evidence and combine this with the clinical experience of a panel of experts to optimize recommendations on how to recognize and manage kidney disease in horses.
Asunto(s)
Enfermedades de los Caballos , Enfermedades Renales , Caballos , Animales , Enfermedades de los Caballos/diagnóstico , Enfermedades de los Caballos/terapia , Enfermedades Renales/veterinaria , ConsensoRESUMEN
BACKGROUND: Pathological fractures have been reported in equids with pituitary pars intermedia dysfunction (PPID) but their prevalence and pathogenesis is unknown. OBJECTIVES: To compare: (1) bone mineral density (BMD) in weight bearing and nonweight bearing bones in PPID+ equids and aged and young PPID- controls; and (2) biomechanical properties of the fourth lumbar vertebral body in PPID+ equids and aged PPID- equids. STUDY DESIGN: Case-control study: five PPID+ equids and six aged and four young PPID- control horses. METHODS: PPID status was based on clinical signs and necropsy examination of the pituitary gland (PG). The lumbar vertebral column, right front third metacarpus (MC3), left hind third metatarsus (MT3), and PG were removed after euthanasia. BMD was determined by quantitative computed tomography of regions of interest (ROI) in each bone and biomechanical testing was performed on the fourth lumbar vertebral body. Serum concentrations of parathormone (PTH), ionised Ca++ , 25-hydroxyvitamin D, and osteocalcin (OC) were also measured. Data were analysed using one-way ANOVA and correlation analyses. RESULTS: BMD of trabecular and cortical regions of interest (ROI) of the third, fourth (L4), and fifth lumbar vertebrae were significantly lower in PPID+ equids as compared with aged (p < 0. 001) and young (p < 0.01) PPID- controls. In contrast, no differences were found in BMD of trabecular or cortical ROIs of MC3 and MT3 between groups. No differences were detected in force at fracture, displacement at fracture, Young's modulus or strain of L4 between PPID+ and aged PPID- horses. No differences were found in serum PTH, ionised Ca++ , 25-hydroxyvitamin D, or OC concentrations between groups. MAIN LIMITATIONS: Limited number of equids studied and variation in test results. CONCLUSIONS: BMD of nonweight bearing bones can be decreased with PPID and could increase risk of developing pathological fractures.
Asunto(s)
Fracturas Espontáneas , Enfermedades de los Caballos , Enfermedades de la Hipófisis , Adenohipófisis Porción Intermedia , Caballos , Animales , Vértebras Lumbares/patología , Estudios de Casos y Controles , Densidad Ósea , Fracturas Espontáneas/patología , Fracturas Espontáneas/veterinaria , Adenohipófisis Porción Intermedia/patología , Enfermedades de la Hipófisis/veterinaria , Enfermedades de la Hipófisis/diagnóstico , Enfermedades de los Caballos/diagnósticoRESUMEN
BACKGROUND: Pituitary pars intermedia dysfunction (PPID) in older equids is commonly recognized by a long hair coat that fails to shed. OBJECTIVE: The aim of this study was to compare hair follicle stages in PPID-affected horses with excessively long hair coats with the stages of normal aged horses (controls) and to compare hair follicle stages in PPID-affected horses after 6 months of treatment with pergolide mesylate with those of control horses. ANIMALS: Eight PPID-affected horses and four normal, age-matched, control horses. METHODS: Skin biopsies were collected from the neck and rump of PPID-affected and control horses. A diagnosis of PPID was established based on hair coat changes and supportive overnight dexamethasone suppression test results. Skin biopsies were repeated after 6 months of treatment with pergolide. The number of hair follicles in anagen (A) or telogen (T) was counted for each skin biopsy using transverse sections. RESULTS: Pretreatment biopsies had a greater percentage of A follicles (neck 96%, rump 95%) and a lower percentage of T follicles (neck 4%, rump 5%) in PPID-affected horses than in control horses (A, neck 15%, rump 25%; and T, neck 85%, rump 75%). After treatment with pergolide, all PPID-affected horses had improved shedding, and the percentages of A follicles (neck 69%, rump 70%) and T follicles (neck 31%, rump 30%) were not different from untreated control horses (A, neck 68%, rump 82%; and T, neck 32%, rump 18%). CONCLUSIONS: These findings document that excessive hair growth (hypertrichosis) in PPID-affected horses is due to persistence of hair follicles in A. Furthermore, treatment with pergolide improved shedding and reduced the percentage of A follicles in PPID-affected horses.
Asunto(s)
Folículo Piloso/patología , Cabello/crecimiento & desarrollo , Enfermedades de los Caballos/metabolismo , Enfermedades de la Hipófisis/veterinaria , Adenohipófisis Porción Intermedia , Envejecimiento , Animales , Agonistas de Dopamina/uso terapéutico , Femenino , Caballos , Masculino , Pergolida/uso terapéutico , Enfermedades de la Hipófisis/tratamiento farmacológico , Enfermedades de la Hipófisis/patologíaRESUMEN
OBJECTIVE: To report technique for, and outcome after, nephrectomy through a ventral median celiotomy in equids. STUDY DESIGN: Case series. ANIMALS: Equids with unilateral renal disease (n = 6), aged 2 months to 18 years, weighing 90-434 kg. METHODS: A ventral median celiotomy was used to access the left or right kidney. To facilitate surgical exposure, the small intestine was reflected towards the diaphragm using laparotomy sponges and the ascending colon was exteriorized and in some cases evacuated. The peritoneum over the affected kidney was incised and blunt dissection used to free the kidney from the retroperitoneal fat, then the renal artery, vein, and ureter were isolated and ligated. Abdominal lavage with sterile saline solution was performed before abdominal closure. RESULTS: Four horses, 1 donkey, and 1 mule had unilateral nephrectomy to treat verminous nephritis (1), idiopathic hematuria (1), and ectopic ureter (4). A ventral median approach provided adequate access to the kidney in all 6 cases. Two horses had postoperative complications (peritonitis, chylous abdominal effusion) that resolved with medical therapy. No complications attributable to nephrectomy were reported by the owners upon follow-up 1-8 years after surgery. CONCLUSIONS: A ventral median approach for nephrectomy can be used for unilateral nephrectomy in equids weighing up to 434 kg.
Asunto(s)
Caballos/cirugía , Nefrectomía/veterinaria , Animales , Femenino , Enfermedades de los Caballos/cirugía , Riñón/cirugía , Enfermedades Renales/cirugía , Enfermedades Renales/veterinaria , Masculino , Nefrectomía/métodosRESUMEN
BACKGROUND: Treatment with phenylbutazone (nonselective COX inhibitor) decreases the diuretic and natriuretic effects of furosemide by nearly 30% but the effects of COX-2 specific inhibitors (firocoxib) and atypical NSAIDs (dipyrone) are unknown. HYPOTHESIS: Furosemide-induced diuresis after pretreatment with firocoxib or dipyrone is diminished to a lesser extent than after pretreatment with phenylbutazone. ANIMALS: Eight healthy mares. METHODS: Each mare received 4 treatments in a prospective experimental crossover study using a replicated 4 × 4 Latin Square design: furosemide alone (FU), furosemide and phenylbutazone (PB), furosemide and firocoxib (FX), and furosemide and dipyrone (DP). After 24 hours of NSAID treatment at recommended dosages, ureteral catheters were placed for continual urine collection. After a 30-minute baseline collection period, furosemide (1.0 mg/kg, IV) was administered, and urine and blood samples were collected for 4 hours. Data were assessed by repeated measures ANOVA. RESULTS: Four-hour urine volume was (mean ± SD) ~25% less (P < .001) after pretreatment with all NSAIDs (PB 19.1 ± 2.1 mL/kg, FX 17.7 ± 3.5 mL/kg, DP 19.1 ± 3.9 mL/kg), as compared to FU (23.4 ± 5.1 mL/kg) (P < .001), but there were no differences between PB, FX, or DP. Interindividual variability in furosemide diuresis after pretreatment with different NSAIDs was observed. CONCLUSIONS AND CLINICAL IMPORTANCE: Though COX-2 selective NSAIDs and dipyrone might have less severe or fever gastrointestinal adverse effects in horses, our data suggest minimal differences in effects on furosemide-induced diuresis, and possibly, risk of nephrotoxicosis.
Asunto(s)
Diuréticos , Furosemida , Animales , Caballos , Femenino , Diuréticos/farmacología , Furosemida/farmacología , Dipirona/farmacología , Estudios Cruzados , Ciclooxigenasa 2 , Estudios Prospectivos , Fenilbutazona/farmacología , Antiinflamatorios no Esteroideos/farmacologíaRESUMEN
We investigated the effects of season and geographic location on detection of nucleic acids of potential enteric pathogens (PEPs) or their toxins (PEP-Ts) in feces of horses ≥6-mo-old in the United States. Results of 3,343 equine diarrhea PCR panels submitted to Idexx Laboratories for horses >6-mo-old were reviewed. Submission months were grouped into 4 seasons, and states were grouped into 4 geographic regions. Logistic regression was performed to assess effects of season and region on detection rates of PEPs and PEP-Ts. Agresti-Coull CIs were determined. Detection rate of Salmonella enterica was higher in the South in summer compared to all other regions, and was also higher in the South in fall compared to the Midwest and Northeast. The Neorickettsia risticii detection rate was lower during summer in the West and higher in fall in the Midwest. Detection of Cryptosporidium spp. was lower during spring, summer, and winter in the West. Differences were not identified for detection rates of Clostridioides difficile, Clostridium perfringens, Lawsonia intracellularis, Rhodococcus equi, equine rotavirus, and equine coronavirus. Overall, our data support seasonal and regional differences in detection rates of S. enterica, N. risticii, and Cryptosporidium spp. in horses ≥6-mo-old in the United States.
Asunto(s)
Clostridioides difficile , Criptosporidiosis , Cryptosporidium , Enfermedades de los Caballos , Animales , Diarrea/veterinaria , Heces/microbiología , Enfermedades de los Caballos/diagnóstico , Enfermedades de los Caballos/epidemiología , Enfermedades de los Caballos/microbiología , Caballos , Estaciones del Año , Estados Unidos/epidemiologíaRESUMEN
Diabetes insipidus (DI) is a rare disorder of horses characterized by profound polyuria and polydipsia (PU/PD), which can be caused by loss of production of arginine vasopressin (AVP). This condition is termed neurogenic or central DI. DI may also develop with absence or loss of AVP receptors or activity on the basolateral membrane of collecting-duct epithelial cells. This condition is termed nephrogenic DI. Equine clinicians may differentiate true DI from more common causes of PU/PD by a systematic diagnostic approach. DI may not be a correctable disorder, and supportive care of affected horses requires an adequate water source.
Asunto(s)
Diabetes Insípida Nefrogénica/veterinaria , Diabetes Insípida/veterinaria , Enfermedades de los Caballos/metabolismo , Desequilibrio Hidroelectrolítico/veterinaria , Animales , Diabetes Insípida/diagnóstico , Diabetes Insípida/metabolismo , Diabetes Insípida Nefrogénica/diagnóstico , Diabetes Insípida Nefrogénica/metabolismo , Femenino , Homeostasis , Enfermedades de los Caballos/diagnóstico , Caballos , Masculino , Vasopresinas/metabolismo , Agua/metabolismo , Desequilibrio Hidroelectrolítico/diagnóstico , Desequilibrio Hidroelectrolítico/metabolismoRESUMEN
OBJECTIVE: To describe refeeding syndrome in an equid without a history of recognized risk factors. CASE SUMMARY: Refeeding syndrome with marked hypophosphatemia developed in an aged miniature donkey gelding during treatment of suspected enterocolitis. Hypophosphatemia (manifested clinically as ileus and neuromuscular weakness) developed despite a short (3 day) history of hyporexia, increased body condition (7/9), and adherence to nutritional recommendations for critically ill equids. Nutritional support included nasogastric enteral feeding with a commercial equine nutrition product claiming to provide 100% of the National Research Council's daily recommended protein, vitamin, and mineral requirements for equids. Hypophosphatemia developed despite this enteral supplementation and was ultimately corrected by intravenous administration of sodium phosphate solution. NEW OR UNIQUE INFORMATION PROVIDED: This case report suggests that risk factors for refeeding syndrome in equids may be broader than previously recognized. Specifically, critically ill equids at risk for insulin dysregulation may have unique nutritional co-morbidities and requirements. This report highlights the need for both broader recognition of risk factors for refeeding syndrome, and revised best-practice nutritional guidelines and supplementation products to improve equine critical care.
Asunto(s)
Enfermedades de los Caballos , Hipofosfatemia , Síndrome de Realimentación , Animales , Enfermedad Crítica , Nutrición Enteral/veterinaria , Equidae , Caballos , Hipofosfatemia/veterinaria , Masculino , Síndrome de Realimentación/veterinariaRESUMEN
BACKGROUND: Rates of detecting ≥1 potential enteric pathogens (PEP) or toxins (PEP-T) in feces, blood, or both of horses ≥6 months of age with enteric disease and impact of multiple detections on outcome of horses with colitis has not been reported. OBJECTIVE: To determine detection rates of PEP/PEP-T in feces, blood, or both of horses with enteric disease and effect of detecting multiple agents on outcome of horses with colitis. ANIMALS: Thirty-seven hundred fifty-three fecal samples submitted to IDEXX Laboratories and 239 fecal and blood samples submitted to Michigan State University's Veterinary Diagnostic Laboratory (MSUVDL). METHODS: Retrospective evaluation of PEP/PEP-T testing results was performed to determine rates of detection of 1 or more PEP/PEP-T. Impact of detecting multiple agents on outcome was assessed in 239 horses hospitalized for colitis. RESULTS: One or more PEP/PEP-T was detected in 1175/3753 (31.3%) and 145/239 (60.7%) of samples submitted to IDEXX Laboratories and MSUVDL, respectively. In a hospitalized cohort, survival to discharge was lower (76%) in horses with 1 agent, compared to horses with either no (88%) or multiple (89%) agents. There was no difference (P = .78) in days of hospitalization between horses with 0 (1-17), 1 (1-33), and > 1 positive (1-20) result. There was no difference in cost of hospitalization (P = .25) between horses with 0 ($2357, $1110-15 553), 1 ($2742, $788-11 005), and >1 positive ($2560, $1091-10 895) result. CONCLUSIONS AND CLINICAL IMPORTANCE: Detection rates of PEP/PEP-T in horses with colitis vary with cohorts and tests performed. Detection of more than 1 PEP or PEP-T did not affect outcome.
Asunto(s)
Colitis , Enfermedades de los Caballos , Animales , Colitis/diagnóstico , Colitis/veterinaria , Heces , Enfermedades de los Caballos/diagnóstico , Caballos , Estudios RetrospectivosRESUMEN
Equine pituitary pars intermedia dysfunction (PPID) is a common endocrine disease of aged horses that shows a similar pathophysiology as Parkinson's Disease (PD) with increased levels of α-synuclein (α-syn). While α-syn is thought to play a pathogenic role in horses with PPID, it is unclear if α-syn is also misfolded in the pars intermedia and could similarly promote self-aggregation and propagation. Consequently, α-syn was isolated from the pars intermedia from groups of healthy young and aged horses, and aged PPID-afflicted horses. Seeding experiments confirmed the prion-like properties of α-syn isolated from PPID-afflicted horses. Next, detection of α-syn fibrils in pars intermedia via transmission electron microscopy (TEM) was exclusive to PPID-afflicted horses. A bank of fragment peptides was designed to further characterize equine α-syn misfolding. Region 62-87 of equine and human α-syn peptides was found to be most prone to aggregation according to Tango bioinformatic program and kinetics of aggregation via a thioflavin T fluorescence assay. In both species, fragment peptide 62-87 is capable of generating mature fibrils as demonstrated by TEM. The combined animal, bioinformatic, and biophysical studies provide evidence that equine α-syn is misfolded in PPID horses.
Asunto(s)
Envejecimiento , Modelos Animales de Enfermedad , Enfermedades de los Caballos/patología , Enfermedades de la Hipófisis/veterinaria , Adenohipófisis Porción Intermedia/patología , Sinucleinopatías/fisiopatología , alfa-Sinucleína/metabolismo , Animales , Enfermedades de los Caballos/metabolismo , Caballos , Enfermedades de la Hipófisis/patologíaRESUMEN
BACKGROUND: Symmetric dimethylarginine (SDMA) is considered a more sensitive indirect estimate of glomerular filtration rate (GFR) than creatinine (Cr). Symmetric dimethylarginine is not affected by sex or muscle mass in small animals. OBJECTIVES: To validate a commercial SDMA immunoassay (IA) for equine serum; to compare SDMA and Cr in cohorts of draft horse breeds; and to assess effects of age, sex, and breed. ANIMALS: One hundred and sixty-five healthy draft horses (0.5-16 years), including 63 Percherons, 52 Clydesdales, and 50 Belgians. METHODS: Cross-sectional study. The SDMA IA was validated for equine serum by comparison to liquid chromatography-mass spectroscopy (LC-MS) results and other methods. Symmetric dimethylarginine and Cr were compared by analysis of variance and correlation analysis. RESULTS: Median and 95% confidence intervals (CIs) for LC-MS (10.0 [9.4, 10.2] µg/dL) and IA (9.7 [9.5, 10.0] µg/dL) SDMA concentrations were strongly correlated (R = .74, P < .001). Symmetric dimethylarginine was lower (P < .01) in Percherons and Belgians, than in Clydesdales. Median values and 95% CI for Cr were 1.3 (1.2, 1.4), 1.4 (1.3, 1.5), and 1.4 (1.3, 1.5) mg/dL (P = .06) for Percherons, Clydesdales, and Belgians, respectively. Symmetric dimethylarginine was correlated to Cr (LC-MS, R = .60, P < .001; IA, R = .66, P < .001). There were no differences in SDMA or Cr between sexes and there were no correlations between age and SDMA or Cr. CONCLUSIONS AND CLINICAL IMPORTANCE: Although a significant breed effect on SDMA concentration was found, differences were small and all medians were <14 µg/dL, the cutoff value to support renal dysfunction in dogs and cats.
Asunto(s)
Enfermedades de los Gatos , Enfermedades de los Perros , Enfermedades de los Caballos , Insuficiencia Renal Crónica , Animales , Arginina/análogos & derivados , Biomarcadores , Gatos , Creatinina , Estudios Transversales , Perros , Enfermedades de los Caballos/diagnóstico , Caballos , Insuficiencia Renal Crónica/veterinariaRESUMEN
To determine whether dexamethasone or hydroxyzine affect intradermal testing (IDT) and allergen-specific IgE serum testing (ASIST) results in horses, these tests were performed serially in five horses without signs of atopic dermatitis before and after treatment with the drugs. IDT consisted of saline, histamine (1:100,000 w/v) and eight commercial extracts; results were evaluated as subjective scores by comparison to saline (0) and histamine (4) and as objective measurement of wheal diameter (mm). After baseline testing, dexamethasone (20 mg) was administered intramuscularly daily for 7 days. Testing was repeated 3-4 h, 7 days, and 14 days after the final dose of dexamethasone. Hydroxyzine (500 mg) was subsequently administered orally twice daily for 7 days. Testing was performed 3-4 h, 3 days, and 7 days after the final dose of hydroxyzine. No differences were found between pre- and post-treatment subjective IDT scores for either drug. However, wheal diameter for histamine and house dust, dust mite mix, and black ant extracts decreased (P < 0.05) at all times post-injection for IDT performed 3-4 h after the final dose of both medications. Wheal diameter returned to pre-treatment levels 14 days after discontinuation of dexamethasone and 7 days after discontinuation of hydroxyzine. No significant changes in ASIST results were found. In conclusion, treatment of horses with dexamethasone or hydroxyzine for 7 days had no effect on ASIST results but did decrease IDT wheal diameters. Based on findings of this study, withdrawal times of 14 and 7 days for dexamethasone and hydroxyzine, respectively, prior to IDT can be recommended.
Asunto(s)
Alérgenos/inmunología , Dexametasona/farmacología , Enfermedades de los Caballos/diagnóstico , Hidroxizina/farmacología , Inmunoglobulina E/sangre , Pruebas Intradérmicas/veterinaria , Animales , Antiinflamatorios/farmacología , Femenino , CaballosRESUMEN
OBJECTIVE: To investigate effects of body condition on permeability of intestinal mucosa in horses. ANIMALS: 13 horses (7 obese and 6 lean) from 8 to 15 years of age. PROCEDURES: Body condition score was assessed, and an oral sugar test (OST) was performed to evaluate glucose and insulin dynamics. Horses were allowed a 2-week diet acclimation period and were then euthanized. Tissue samples were collected from the jejunum, ileum, cecum, pelvic flexure, right dorsal colon, and rectum. Mucosal permeability was assessed by measuring transepithelial resistance and lipopolysaccharide (LPS) flux across tissue samples mounted in Ussing chambers. RESULTS: 5 obese horses and 1 lean horse had evidence of insulin dysregulation, whereas 1 obese and 5 lean horses had no abnormalities in results of the OST. Results for the OST were not available for 1 obese horse. Mucosal transepithelial resistance did not differ in any intestinal segment between obese and lean horses. Obese horses had a significantly higher LPS flux across jejunal mucosa, compared with results for lean horses, but there were no significant differences between obese and lean horses for other intestinal segments. CONCLUSIONS AND CLINICAL RELEVANCE: Obese horses may have had greater paracellular mucosal permeability of jejunal mucosa to LPS, compared with that for lean horses. This finding was consistent with data for the gastrointestinal mucosa of humans and mice and supported the hypothesis that obese horses may be at higher risk from chronic exposure to increased amounts of LPS, compared with the risk for lean horses.
Asunto(s)
Enfermedades de los Caballos/metabolismo , Mucosa Intestinal/metabolismo , Obesidad/veterinaria , Animales , Constitución Corporal , Ciego/metabolismo , Colon/metabolismo , Absorción Gastrointestinal , Glucosa/metabolismo , Caballos , Insulina/metabolismo , Yeyuno/metabolismo , Lipopolisacáridos/metabolismo , Obesidad/metabolismo , PermeabilidadRESUMEN
BACKGROUND: Obtaining commercial fluids for intravenous administration (IVF) was challenging during a recent shortage. This necessitated use of custom-made non-sterile fluids for intravenous administration (JUGs) in some hospitals. There are no studies comparing outcome of horses treated with JUG versus IVF and limited information is available about adverse effects of JUGs. HYPOTHESIS/OBJECTIVES: To evaluate death, complications, blood pH, and plasma electrolyte concentrations of horses that received JUG versus IVFs. ANIMALS: One hundred eighty-six horses that received IVFs and 37 that received JUGs. METHODS: A retrospective review of medical records was performed to identify horses that received IVFs or JUGs during hospitalization. Information including survival to discharge, complications (fever [>38.5°C], jugular vein phlebitis/thrombosis, arrhythmia, or laminitis), blood pH, and plasma electrolyte concentrations were obtained. RESULTS: There was no difference (P = .67) in survival to discharge for horses that received JUGs (78%) compared to horses that received IVFs (87%). Horses that received JUGs were more likely to develop a jugular vein complication (3 of 37 versus 1 of 186, odds ratio 17.2 [95% CI 1.9-389.8], P = .04). Horses that received JUGs were more likely to have electrolyte abnormalities consistent with hyperchloremic metabolic acidosis. CONCLUSION AND CLINICAL IMPORTANCE: Veterinarians using JUGs should obtain informed client consent because of a potential increased risk of jugular vein complications. Chloride content of JUGs should be considered to limit development of hyperchloremic metabolic acidosis.
Asunto(s)
Composición de Medicamentos/veterinaria , Fluidoterapia/veterinaria , Enfermedades de los Caballos/inducido químicamente , Animales , Femenino , Enfermedades de los Caballos/tratamiento farmacológico , Enfermedades de los Caballos/mortalidad , Caballos , Infusiones Intravenosas , Venas Yugulares , Masculino , Estudios RetrospectivosRESUMEN
Previous research has determined that maintaining young animals in stalls is detrimental to their bone health, while the addition of 50 to 82-m sprints 5 d/week aids in counteracting the reduction of bone strength from confinement. The current research aims to determine if 1 or 3 d/week of sprinting affords the same benefits to bone as 5 d/week of sprinting compared to animals confined with no sprinting. Twenty-four Holstein bull calves were obtained from the Michigan State University Dairy Cattle Teaching and Research Center. At 9 wk of age, calves were randomly assigned to treatments of 1, 3, or 5 d/week of sprint exercise, or to the confined control group sprinted 0 d/week. Each treatment had 6 calves. Individual sprinting bouts included a single sprint down a 71-m concrete aisle. For the duration of the 6-wk study, calves were housed at the MSU Beef Cattle Teaching and Research Center in stalls which afforded calves room to stand, lay down, and turn around. Serum was collected weekly via jugular venipuncture to obtain concentrations of osteocalcin (OC) and C-telopeptide crosslaps of type I collagen (CTX-1)-markers of bone formation and degradation, respectively. Sprints were videotaped weekly to determine stride frequency and sprint velocity. On day 42, calves were humanely euthanized at the Michigan State University Meat Lab and both front limbs were immediately harvested. Computed tomography scans and mechanical testing were performed on the left fused third and fourth metacarpal bones. Serum OC concentration was greatest for calves sprinted 5 d/week (P < 0.001). Calves sprinted 5 d/week had both greater stride frequency (P < 0.05) and lower sprint velocity (P < 0.05). All exercise treatments experienced greater dorsal cortical widths compared to control animals (P < 0.01). Through mechanical testing, fracture forces of all sprinting treatments were determined to be greater than the control treatment (P < 0.02). Results from this study support that sprinting 1, 3, or 5 d/week during growth can increase bone health and cause favorable alterations in bone markers. While all exercise treatments had over a 20% increase to fracture force, calves sprinted 1 d/week sprinted only 426 m over the 6-wk study and still experienced over a 20% increase in bone strength compared to confined calves. This study demonstrates the remarkably few strides at speed needed to enhance bone strength and emphasizes the danger to skeletal strength if sprinting opportunities are not afforded.
Asunto(s)
Caballos/fisiología , Animales , Biomarcadores/sangre , Resorción Ósea/fisiopatología , Huesos/fisiología , Bovinos , Colágeno Tipo I/sangre , Masculino , Osteocalcina/sangre , Osteogénesis/fisiología , Condicionamiento Físico Animal , Distribución AleatoriaRESUMEN
There is great need for veterinary care for working equids worldwide. Addressing this need provides an opportunity for veterinary students to gain primary care experience. An annual two week collaborative outreach and educational program with Michigan State University (MSU), the Universidad Nacional Autónoma de México (UNAM) and the Universidad Veracruzana (UV) was developed to provide care for working equids in rural Mexican communities. From 2017 to 2019 24 US veterinary students and 25 Mexican veterinary students, interns and residents examined, vaccinated and dewormed more than 2200 equids and performed more than 80 castrations, 100 rectal palpations for pregnancy diagnosis, 220 dental floats and 320 hoof trims. They also treated many wounds, sarcoids, vampire bat bites and tick infestations and also saw unusual cases including tetanus, eye injuries, nuchal bursitis, cervical vertebral malformation and suspected vesicular stomatitis. Development of the collaborative MSU-UNAM-UV Equine Welfare in Practice Clerkship required vision, learning, relationship building, creativity, fund-raising and perseverance to develop and agree on mutually beneficial objectives for all participants. The project is largely financed through private donations and supplies provided by pharmaceutical companies. The outcome has been a highly successful program that could be used as a model by other Colleges of Veterinary Medicine world-wide.